Detailed answers about MEDICAL ACME RESEARCH SOLUTIONS LTD, including incorporation, status, business activity, and accounts information.
When was MEDICAL ACME RESEARCH SOLUTIONS LTD founded?
MEDICAL ACME RESEARCH SOLUTIONS LTD was officially incorporated on 27 October 2025 and is registered under company number 16813935. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MEDICAL ACME RESEARCH SOLUTIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MEDICAL ACME RESEARCH SOLUTIONS LTD?
MEDICAL ACME RESEARCH SOLUTIONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MEDICAL ACME RESEARCH SOLUTIONS LTD do?
MEDICAL ACME RESEARCH SOLUTIONS LTD operates in the following sectors: 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is MEDICAL ACME RESEARCH SOLUTIONS LTD's registered address?
The registered office address of MEDICAL ACME RESEARCH SOLUTIONS LTD is 122 TIPTON ROAD, WOODSETTON, DUDLEY, ENGLAND, DY3 1BY. This is the official address filed with Companies House for legal and statutory correspondence.
Is MEDICAL ACME RESEARCH SOLUTIONS LTD financially stable?
Financial accounts for MEDICAL ACME RESEARCH SOLUTIONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.